Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.

Français
Author : 
Moran, T ; Wei, J ; Cobo, M ; Qian, X ; Domine, M ; Zou, Z & al
Newspaper edition : 
Ann. Oncol. - Année 2014 - Volume 25 - Page 2147-55 - PMID 25164908